The Company has likely successfully managed through a series of 'toxic' financing facilities with New York City investment groups that converted over 1.20 billion shares
which ultimately placed downward pressure on the company's market price, dropping it from a high of $0.24
The Company will likely announce that there are no additional outstanding toxic financing facilities that would allow debtors to convert any more Company stock.
In addition, the Company has deflected a frivolous lawsuit.